To the best of our knowledge, this is the first study to investigate the value of pretreatment serum CEA levels for guiding ACT in rectal cancer patients with ypTis-3N0 after neoadjuvant radiotherapy and surgery. Here, CEACAM5 is linked to rectal cancer.